Review




Structured Review

Mimotopes 15mer peptides
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
15mer Peptides, supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pmc11825025-134-0-5?v=Mimotopes
Average 90 stars, based on 1 article reviews
15mer peptides - by Bioz Stars, 2026-07
90/100 stars

Images

1) Product Images from "Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes"

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

Journal: PLOS ONE

doi: 10.1371/journal.pone.0318098

Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools,  15mer peptides,  and tested predicted minimal epitopes.
Figure Legend Snippet: Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, 15mer peptides, and tested predicted minimal epitopes.

Techniques Used: Sequencing

Cohort CA: FluoroSpot IFN-γ and GzB responses for non-protected participant v32 (HLA A*03:03 (A03)/A*03:03) (A03), B*07:02 (B07)/B*07:02 (B07) to AMA1 Ap8 and Ap10 peptide subpools,  15mer peptides,  and predicted minimal epitopes.
Figure Legend Snippet: Cohort CA: FluoroSpot IFN-γ and GzB responses for non-protected participant v32 (HLA A*03:03 (A03)/A*03:03) (A03), B*07:02 (B07)/B*07:02 (B07) to AMA1 Ap8 and Ap10 peptide subpools, 15mer peptides, and predicted minimal epitopes.

Techniques Used: Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v12 (HLA A*02:02 (A02)/A*32:01 (A01), B*35:01 (B07)/B*44:03 (B44) to AMA1 Ap8  15mer  peptide and synthesized predicted epitope.
Figure Legend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v12 (HLA A*02:02 (A02)/A*32:01 (A01), B*35:01 (B07)/B*44:03 (B44) to AMA1 Ap8 15mer peptide and synthesized predicted epitope.

Techniques Used: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v24 (HLA A*02:01 (A02)/A*30:01 (A01A03), B*35:01 (B07)/B*42:02 (B07) to AMA1 Ap1, Ap3 and Ap9 peptide pools,  15mer peptides,  and synthesized predicted epitopes.
Figure Legend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v24 (HLA A*02:01 (A02)/A*30:01 (A01A03), B*35:01 (B07)/B*42:02 (B07) to AMA1 Ap1, Ap3 and Ap9 peptide pools, 15mer peptides, and synthesized predicted epitopes.

Techniques Used: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for non-protected participant v33 ( HLA A*23:01 (A24)/A*33:03 (A03), B*51:01 (B07)/B*58:01 (B58) to AMA1 Ap4, Ap8 and Ap10 peptide pools,  15mer peptides,  and synthesized predicted epitopes.
Figure Legend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for non-protected participant v33 ( HLA A*23:01 (A24)/A*33:03 (A03), B*51:01 (B07)/B*58:01 (B58) to AMA1 Ap4, Ap8 and Ap10 peptide pools, 15mer peptides, and synthesized predicted epitopes.

Techniques Used: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ responses for non-protected participant v35 (HLA A*02:01 (A02)/A*02:06 (A02), B*39:05 (B27)/B*58:01 (B58) to AMA1 Ap8 peptide pool,  15mer  component peptides, and synthesized predicted epitopes within active 15mers.
Figure Legend Snippet: Cohort CAT: FluoroSpot IFN-γ responses for non-protected participant v35 (HLA A*02:01 (A02)/A*02:06 (A02), B*39:05 (B27)/B*58:01 (B58) to AMA1 Ap8 peptide pool, 15mer component peptides, and synthesized predicted epitopes within active 15mers.

Techniques Used: Synthesized, Sequencing



Similar Products

86
Synpeptide Co Ltd lrrk2 928 942 15mer peptide
Protection from hydrogen‐deuterium exchange induced by molecular glue binding. a,b) Uptake plots (i‐vi) of six peptide regions of 14‐3‐3σ displaying % deuterium incorporation in the unbound (black), <t>ERα/LRRK2</t> bound (pink/purple) and FC‐A stabilized (green) condition. HDX profiles involved with binding partners ERα and <t>LRRK2</t> are displayed on the left and right, respectively. * represents significant differences between protein complex conditions at 24 h ( p ≤ 0.05). c,d) HDX difference profile of 14‐3‐3/ERα (left) or 14‐3‐3/LRRK2 (right) with and without molecular glue, FC‐A at 24h mapped onto the 14‐3‐3σ structure (PDB: 4JDD (left), 5MY9 (right)). The location of the uptake plots of peptides i‐vi are labelled on the 14‐3‐3 structure.
Lrrk2 928 942 15mer Peptide, supplied by Synpeptide Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pmc12591169-112-10-17?v=Synpeptide+Co+Ltd
Average 86 stars, based on 1 article reviews
lrrk2 928 942 15mer peptide - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Synpeptide Co Ltd erα 581 595 15mer peptide
Protection from hydrogen‐deuterium exchange induced by molecular glue binding. a,b) Uptake plots (i‐vi) of six peptide regions of 14‐3‐3σ displaying % deuterium incorporation in the unbound (black), <t>ERα/LRRK2</t> bound (pink/purple) and FC‐A stabilized (green) condition. HDX profiles involved with binding partners ERα and <t>LRRK2</t> are displayed on the left and right, respectively. * represents significant differences between protein complex conditions at 24 h ( p ≤ 0.05). c,d) HDX difference profile of 14‐3‐3/ERα (left) or 14‐3‐3/LRRK2 (right) with and without molecular glue, FC‐A at 24h mapped onto the 14‐3‐3σ structure (PDB: 4JDD (left), 5MY9 (right)). The location of the uptake plots of peptides i‐vi are labelled on the 14‐3‐3 structure.
Erα 581 595 15mer Peptide, supplied by Synpeptide Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pmc12591169-112-1-6?v=Synpeptide+Co+Ltd
Average 86 stars, based on 1 article reviews
erα 581 595 15mer peptide - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
GenScript corporation overlapping 15mer peptides
Protection from hydrogen‐deuterium exchange induced by molecular glue binding. a,b) Uptake plots (i‐vi) of six peptide regions of 14‐3‐3σ displaying % deuterium incorporation in the unbound (black), <t>ERα/LRRK2</t> bound (pink/purple) and FC‐A stabilized (green) condition. HDX profiles involved with binding partners ERα and <t>LRRK2</t> are displayed on the left and right, respectively. * represents significant differences between protein complex conditions at 24 h ( p ≤ 0.05). c,d) HDX difference profile of 14‐3‐3/ERα (left) or 14‐3‐3/LRRK2 (right) with and without molecular glue, FC‐A at 24h mapped onto the 14‐3‐3σ structure (PDB: 4JDD (left), 5MY9 (right)). The location of the uptake plots of peptides i‐vi are labelled on the 14‐3‐3 structure.
Overlapping 15mer Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pm39972124-508-5-10?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
overlapping 15mer peptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Mimotopes 15mer peptides
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
15mer Peptides, supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pmc11825025-134-0-5?v=Mimotopes
Average 90 stars, based on 1 article reviews
15mer peptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Mimotopes csp, ama1 and trap peptide subpools 15mer peptides
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
Csp, Ama1 And Trap Peptide Subpools 15mer Peptides, supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pm39946433-80-1-11?v=Mimotopes
Average 90 stars, based on 1 article reviews
csp, ama1 and trap peptide subpools 15mer peptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation peptide scan (15mers with 11 amino acid overlap) covering the entire nucleoprotein (protein id: p0dtc9)
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
Peptide Scan (15mers With 11 Amino Acid Overlap) Covering The Entire Nucleoprotein (Protein Id: P0dtc9), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pm39813973-52-16-29?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
peptide scan (15mers with 11 amino acid overlap) covering the entire nucleoprotein (protein id: p0dtc9) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation 1 µg/ml pool of overlapping peptides (15mers with 11 amino acid overlap) covering the rsv protein
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
1 µg/Ml Pool Of Overlapping Peptides (15mers With 11 Amino Acid Overlap) Covering The Rsv Protein, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/ppr0953734-154-62-64?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
1 µg/ml pool of overlapping peptides (15mers with 11 amino acid overlap) covering the rsv protein - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH overlapping 15mer rbd peptide pools at 1 μg/ml
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
Overlapping 15mer Rbd Peptide Pools At 1 μg/Ml, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pmc11626164-291-5-14?v=JPT+Peptide+Technologies+GmbH
Average 90 stars, based on 1 article reviews
overlapping 15mer rbd peptide pools at 1 μg/ml - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH 15mer rdrp peptide pools
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
15mer Rdrp Peptide Pools, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pm39589869-400-5-14?v=JPT+Peptide+Technologies+GmbH
Average 90 stars, based on 1 article reviews
15mer rdrp peptide pools - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation 15mer peptides covering the unique ie1 protein coding sequence gp123
Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, <t> 15mer peptides, </t> and tested predicted minimal epitopes.
15mer Peptides Covering The Unique Ie1 Protein Coding Sequence Gp123, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/15mer+peptides/pm39298998-262-1-19?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
15mer peptides covering the unique ie1 protein coding sequence gp123 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Protection from hydrogen‐deuterium exchange induced by molecular glue binding. a,b) Uptake plots (i‐vi) of six peptide regions of 14‐3‐3σ displaying % deuterium incorporation in the unbound (black), ERα/LRRK2 bound (pink/purple) and FC‐A stabilized (green) condition. HDX profiles involved with binding partners ERα and LRRK2 are displayed on the left and right, respectively. * represents significant differences between protein complex conditions at 24 h ( p ≤ 0.05). c,d) HDX difference profile of 14‐3‐3/ERα (left) or 14‐3‐3/LRRK2 (right) with and without molecular glue, FC‐A at 24h mapped onto the 14‐3‐3σ structure (PDB: 4JDD (left), 5MY9 (right)). The location of the uptake plots of peptides i‐vi are labelled on the 14‐3‐3 structure.

Journal: Advanced Science

Article Title: Hydrogen‐Deuterium Exchange Mass Spectrometry for Molecular Glue Characterization

doi: 10.1002/advs.202508543

Figure Lengend Snippet: Protection from hydrogen‐deuterium exchange induced by molecular glue binding. a,b) Uptake plots (i‐vi) of six peptide regions of 14‐3‐3σ displaying % deuterium incorporation in the unbound (black), ERα/LRRK2 bound (pink/purple) and FC‐A stabilized (green) condition. HDX profiles involved with binding partners ERα and LRRK2 are displayed on the left and right, respectively. * represents significant differences between protein complex conditions at 24 h ( p ≤ 0.05). c,d) HDX difference profile of 14‐3‐3/ERα (left) or 14‐3‐3/LRRK2 (right) with and without molecular glue, FC‐A at 24h mapped onto the 14‐3‐3σ structure (PDB: 4JDD (left), 5MY9 (right)). The location of the uptake plots of peptides i‐vi are labelled on the 14‐3‐3 structure.

Article Snippet: Lypholized ERα 581‐595 15mer peptide (Ac‐KYYITGEAEGFPA(pT)V‐COOH, Synpeptide Ltd) and lypholized LRRK2 928‐942 15mer peptide (Ac‐NLQRHSN(pS)LGPIFDH‐CONH 2 , Synpeptide Ltd) were diluted into 100 mM ammonium acetate to make peptide stocks of 1 mM and stored at ‐20 °C prior to use.

Techniques: Binding Assay

Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools,  15mer peptides,  and tested predicted minimal epitopes.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CA: FluoroSpot IFN-γ and GzB responses of protected participant v90 (HLA A*33:03 (A03)/A*33:0 (A03), B*44:03 (B44)/B*58:01 (B58) to AMA1 Ap8, Ap10 and Ap11 peptide subpools, 15mer peptides, and tested predicted minimal epitopes.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Sequencing

Cohort CA: FluoroSpot IFN-γ and GzB responses for non-protected participant v32 (HLA A*03:03 (A03)/A*03:03) (A03), B*07:02 (B07)/B*07:02 (B07) to AMA1 Ap8 and Ap10 peptide subpools,  15mer peptides,  and predicted minimal epitopes.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CA: FluoroSpot IFN-γ and GzB responses for non-protected participant v32 (HLA A*03:03 (A03)/A*03:03) (A03), B*07:02 (B07)/B*07:02 (B07) to AMA1 Ap8 and Ap10 peptide subpools, 15mer peptides, and predicted minimal epitopes.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v12 (HLA A*02:02 (A02)/A*32:01 (A01), B*35:01 (B07)/B*44:03 (B44) to AMA1 Ap8  15mer  peptide and synthesized predicted epitope.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v12 (HLA A*02:02 (A02)/A*32:01 (A01), B*35:01 (B07)/B*44:03 (B44) to AMA1 Ap8 15mer peptide and synthesized predicted epitope.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v24 (HLA A*02:01 (A02)/A*30:01 (A01A03), B*35:01 (B07)/B*42:02 (B07) to AMA1 Ap1, Ap3 and Ap9 peptide pools,  15mer peptides,  and synthesized predicted epitopes.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for protected participant v24 (HLA A*02:01 (A02)/A*30:01 (A01A03), B*35:01 (B07)/B*42:02 (B07) to AMA1 Ap1, Ap3 and Ap9 peptide pools, 15mer peptides, and synthesized predicted epitopes.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ and GzB responses for non-protected participant v33 ( HLA A*23:01 (A24)/A*33:03 (A03), B*51:01 (B07)/B*58:01 (B58) to AMA1 Ap4, Ap8 and Ap10 peptide pools,  15mer peptides,  and synthesized predicted epitopes.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CAT: FluoroSpot IFN-γ and GzB responses for non-protected participant v33 ( HLA A*23:01 (A24)/A*33:03 (A03), B*51:01 (B07)/B*58:01 (B58) to AMA1 Ap4, Ap8 and Ap10 peptide pools, 15mer peptides, and synthesized predicted epitopes.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Synthesized, Sequencing

Cohort CAT: FluoroSpot IFN-γ responses for non-protected participant v35 (HLA A*02:01 (A02)/A*02:06 (A02), B*39:05 (B27)/B*58:01 (B58) to AMA1 Ap8 peptide pool,  15mer  component peptides, and synthesized predicted epitopes within active 15mers.

Journal: PLOS ONE

Article Title: Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

doi: 10.1371/journal.pone.0318098

Figure Lengend Snippet: Cohort CAT: FluoroSpot IFN-γ responses for non-protected participant v35 (HLA A*02:01 (A02)/A*02:06 (A02), B*39:05 (B27)/B*58:01 (B58) to AMA1 Ap8 peptide pool, 15mer component peptides, and synthesized predicted epitopes within active 15mers.

Article Snippet: 15mer peptides were synthesized by Mimotopes, VIC, Australia.

Techniques: Synthesized, Sequencing